Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.

Abstract:

:Oxaliplatin-based chemotherapy is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC), which, in combination with targeted therapies and a sequential treatment approach using all active agents, has extended median overall survival to 2 years and beyond. Prolonged survival brings into focus the burden of treatment, in terms of associated toxicities and quality of life, and attention is now being paid to lowering the toxicity burden for patients receiving chemotherapy for mCRC without compromising efficacy. The use of oxaliplatin can lead to the development of sensory neuropathy, which commonly limits the dose and/or duration of treatment that can be administered. Temporary withdrawal of oxaliplatin (treatment holidays) has been shown to be an effective strategy for the management of this adverse effect. Data from randomized controlled trials indicate that a formalized stop-and-go approach to the delivery of oxaliplatin does not compromise efficacy, and indeed for some patients may prove beneficial by allowing them to continue treatment for longer periods. This paper presents a critical review of the evidence to support the utility of treatment interruption and reintroduction of oxaliplatin for the long-term management of mCRC.

journal_name

Oncology

journal_title

Oncology

authors

Grothey A

doi

10.1159/000323491

subject

Has Abstract

pub_date

2010-01-01 00:00:00

pages

389-99

issue

5-6

eissn

0030-2414

issn

1423-0232

pii

000323491

journal_volume

79

pub_type

杂志文章,评审

相关文献

ONCOLOGY文献大全
  • Testicular lymphoma: organ-specific treatment did not improve outcome.

    abstract:OBJECTIVES:To assess whether the use of an organ-specific treatment could improve event-free survival (EFS) and overall survival as endpoints in testicular lymphoma in the early stage: IE and IIE. METHODS:Thirty-four patients were selected to be treated with orchiectomy following six cycles of anthracycline-based comb...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000081319

    authors: Avilés A,Neri N,Huerta-Guzmán J,Pérez F,Fernández R

    更新日期:2004-01-01 00:00:00

  • Companion diagnostics in oncology - current status and future aspects.

    abstract::A large number of targeted anticancer drugs are currently under development and most of them will have a companion diagnostic linked to their use. If a diagnostic assay is developed in conjunction with a targeted anticancer drug, such an assay will later end up determining the conditions for the use of the drug after ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000353454

    authors: Jørgensen JT

    更新日期:2013-01-01 00:00:00

  • Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial.

    abstract::The efficacy of recombinant interferon-alpha 2 in the treatment of advanced hairy cell leukaemia is investigated in 31 patients. Preliminary results show a complete and partial response rate of 69%. An optimal dose study utilizing maximal stimulation of an interferon-dependent pathway was carried out in 5 patients. Th...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226076

    authors: Huber C,Flener R,Gastl G

    更新日期:1985-01-01 00:00:00

  • Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions.

    abstract:BACKGROUND:It is well recognized that distinguishing benign from malignant papillary lesions of the breast may pose challenging diagnostic problems. To prospectively evaluate the potential role of mammography, ultrasound and image-guided core biopsy in the diagnosis of papillary lesions of the breast. METHODS:1,442 wo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000074643

    authors: Puglisi F,Zuiani C,Bazzocchi M,Valent F,Aprile G,Pertoldi B,Minisini AM,Cedolini C,Londero V,Piga A,Di Loreto C

    更新日期:2003-01-01 00:00:00

  • Testicular seminoma: results of treatment at the Northern Israel Oncology Center.

    abstract::The survival, and the patterns and mechanisms of failure of 41 patients with pure testicular seminoma treated at the Northern Israel Oncology Center from 1968 to 1983 were analyzed. The actuarial 5-year survival of all patients was 85.4% and of stage I patients, 92.2%. Treatment failures were analyzed. The following c...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226341

    authors: Stein M,Steiner M,Koten A,Cohen Y,Robinson E

    更新日期:1986-01-01 00:00:00

  • Therapeutic management of stage I-II high-grade primary gastric lymphomas.

    abstract::The best treatment for primary gastric lymphomas (PGL) has not yet been defined. Eighty-three patients with stage I/II PGL are documented, focusing on prognostic factors, treatment-related morbidity and mortality, and therapeutic outcome. Chemotherapy improved survival in comparison to local treatments, i.e. gastrecto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011978

    authors: Ferreri AJ,Cordio S,Paro S,Ponzoni M,Freschi M,Veglia F,Villa E

    更新日期:1999-01-01 00:00:00

  • Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status.

    abstract:OBJECTIVES AND METHODS:The association oxaliplatin (OXA)-5-fluorouracil/folinic acid (FUFA) is currently a standard first-line treatment for advanced colorectal cancer. The main objective of this experimental study was to examine the cytotoxic effects resulting from the addition of ionizing radiation (Rgamma) to the co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000069308

    authors: Magné N,Fischel JL,Formento P,Etienne MC,Dubreuil A,Marcié S,Lagrange JL,Milano G

    更新日期:2003-01-01 00:00:00

  • Targeted therapy in the treatment of metastatic renal cell cancer.

    abstract::The treatment of metastatic renal cell carcinoma (MRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting vascular endothelial growth factor, platelet-derived growth factor and mammalian target of rapamycin (mTOR) pathways. New agents including the small-molecule targe...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000258504

    authors: Di Lorenzo G,Scagliarini S,Di Napoli M,Scognamiglio F,Rizzo M,Carteni' G

    更新日期:2009-01-01 00:00:00

  • Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.

    abstract::Twenty-two patients with metastatic breast carcinoma were treated with a combination of cisplatin (100 mg/m2 i.v. day 1) and etoposide (100 mg/m2 i.v. days 1-3). Eligible patients had measurable disease with normal organ functions, performance status < 3, age < 70 years and no previous chemotherapy for metastatic dise...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227364

    authors: Lluch A,Azagra P,Cervantes A,Muñoz M,Alberola V,Santabarbara P,García-Conde J

    更新日期:1994-07-01 00:00:00

  • Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.

    abstract:PURPOSE:To confirm the safety and effectiveness of techniques to assist radiofrequency ablation (RFA) for difficult cases, we retrospectively evaluated successful treatment rates, early complications and local tumor progressions. PATIENTS AND METHODS:Between June 1999 and April 2009, a total of 341 patients with 535 n...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000315236

    authors: Inoue T,Minami Y,Chung H,Hayaishi S,Ueda T,Tatsumi C,Takita M,Kitai S,Hatanaka K,Ishikawa E,Yada N,Hagiwara S,Ueshima K,Kudo M

    更新日期:2010-07-01 00:00:00

  • Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.

    abstract:OBJECTIVES:Angiogenesis plays an important role in ovarian cancer. The interaction of platelet-derived growth factor receptor-beta (PDGFR-β) with vascular endothelial growth factor (VEGF) in the process of angiogenesis may represent an essential feature in the progression of the disease. METHODS:Patients with epitheli...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000351032

    authors: Mathey S,Graeser MK,Zu Eulenburg C,Woelber L,Trillsch F,Jaenicke F,Müller V,Milde-Langosch K,Mahner S

    更新日期:2013-01-01 00:00:00

  • HER-targeted tyrosine-kinase inhibitors.

    abstract::Improved understanding of tumor biology has led to the identification of numerous growth factors that are involved in malignant transformation and tumor progression. Many of these factors induce cellular responses through receptors with intrinsic tyrosine kinase (TK) activity. Therefore, inhibiting receptor TK activit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000066198

    authors: Baselga J,Hammond LA

    更新日期:2002-01-01 00:00:00

  • Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).

    abstract:BACKGROUND AND AIMS:Ovarian clear cell carcinoma (CCC) has a poorer prognosis than other subtypes of ovarian cancer. In this study, we evaluated the responsiveness to second-line chemotherapy in recurrent ovarian CCC. METHODS:The MITO-9 project investigated a cohort of patients observed between 1991 and 2007 in 20 cen...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000358730

    authors: Esposito F,Cecere SC,Magazzino F,Katsaros D,Ottaiano A,Gadducci A,Pisano C,Scalone S,Rabaiotti E,Salutari V,Cormio G,Canuto EM,Greggi S,Savarese A,Marinaccio M,Scollo P,Santeufemia DA,Sacco C,Facchini G,Pignata S

    更新日期:2014-01-01 00:00:00

  • Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.

    abstract:BACKGROUND:The RUNX proteins are a family of transcriptional factors that have essential functions during embryogenesis and development, whereas deregulation in expression of RUNXs is often linked to tumor formation. To date, there has been no study describing the precise expression, prognostic impact and methylation s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000135350

    authors: Tonomoto Y,Tachibana M,Dhar DK,Onoda T,Hata K,Ohnuma H,Tanaka T,Nagasue N

    更新日期:2007-01-01 00:00:00

  • Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix.

    abstract::Previous studies have demonstrated a rise in serum alpha-1-antitrypsin at advanced stages of malignancy. These, together with results of animal experiments with another anti-proteinase, aprotinin, have prompted studies of the plasma alpha-1-antitrypsin in the early stages of malignancy, using cervical carcinoma as a m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225093

    authors: Latner AL,Turner GA,Lamin MM

    更新日期:1976-01-01 00:00:00

  • Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.

    abstract:AIM:The aim of this study was to assess the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. METHODS:A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen rec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341537

    authors: Sánchez-Muñoz A,Román-Jobacho A,Pérez-Villa L,Sánchez-Rovira P,Miramón J,Pérez D,Sáez MI,de Luque V,Medina L,Ramírez-Tortosa CL,Vicioso L,Medina JA,Ribelles N,Alba E

    更新日期:2012-01-01 00:00:00

  • Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.

    abstract::We evaluated changes in serum albumin concentrations in 15 patients with advanced malignancy who were also receiving cisplatin. All 15 patients had serial measurements of serum albumin. The decrease in serum albumin from the time of the first dose of cisplatin to death correlated with liver platinum levels at autopsy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226100

    authors: Nanji AA,Mikhael NZ,Stewart DJ

    更新日期:1986-01-01 00:00:00

  • Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.

    abstract:BACKGROUND:Ethnic disparities in cancers are associated with variability in clinical outcomes. We present a Surveillance Epidemiology and End RESULTS (SEER)-based outcome analysis of multiethnic Waldenström's macroglobulinemia (WM) patients. METHODS:Adult WM patients diagnosed in 1992 or later (n = 3,175) were analyze...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360992

    authors: Ailawadhi S,Kardosh A,Yang D,Cozen W,Patel G,Alamgir MA,Chanan-Khan AA

    更新日期:2014-01-01 00:00:00

  • The Role of Adjuvant Radiation Therapy for Locoregionally Advanced Papillary Thyroid Carcinoma.

    abstract:OBJECTIVES:To investigate the role of adjuvant radiation therapy in locoregional control in patients with locoregionally advanced papillary thyroid carcinoma (pT4 or pN1b) based on a comparison of a group that received radiation therapy and a group that did not receive radiation therapy. METHODS:A retrospective analys...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000444393

    authors: Lee NK,Kim CY,Baek SK,Jung KY

    更新日期:2016-01-01 00:00:00

  • Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

    abstract::Abundant expression of thymidine phosphorylase (TP) mRNA and protein was observed in human carcinoma tissues relative to the corresponding normal tissues. However, the distribution of cells that express TP has not yet been determined. In this study, we examined enzyme activity of TP in 24 primary colorectal carcinoma ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000065064

    authors: Mimori K,Matsuyama A,Yoshinaga K,Yamashita K,Masuda T,Inoue H,Ueo H,Mori M

    更新日期:2002-01-01 00:00:00

  • Localisation of Hodgkin's disease and lymphomas by 67-gallium substraction scanning.

    abstract::67Ga-subtraction scan was found to be useful and a promising new method for the pre-treatment evaluation of the patient with Hodgkin's disease or non-Hodgkin's lymphoma. The scan appeared to be most accurate in the neck, chest, and axillary regions. It appears to offer a means of increasing the accuracy of evaluating ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225217

    authors: Krolikiewicz H,Maruyama Y,Deland FH,Beihn RM,Hafner T,Utley JF

    更新日期:1977-01-01 00:00:00

  • Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

    abstract:BACKGROUND:Whether recurrence after surgery and primary metastatic pancreatic cancer should be included in the same category when conducting gemcitabine-based clinical trials remains controversial. OBJECTIVE:To clarify the outcomes of recurrent and metastatic pancreatic cancers. METHODS:326 patients who received gemc...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000236022

    authors: Hashimoto K,Ueno H,Ikeda M,Kojima Y,Hagihara A,Kondo S,Morizane C,Okusaka T

    更新日期:2009-01-01 00:00:00

  • Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.

    abstract::The Abelson-virus-induced murine lymphosarcoma cell line RAW117-P and its in vivo selected highly malignant and metastatic variant RAW117-H10 have been studied for their growth in vivo, in vitro and in semi-solid agar. The highly malignant metastatic variant RAW117-H10 cells killed syngeneic Balb/c mice rapidly and fo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226473

    authors: Joshi SS,Sharp JG,Brunson KW

    更新日期:1987-01-01 00:00:00

  • Bone scintigrams: their clinical usefulness in patients with breast carcinoma.

    abstract::A comparison of bone scintigrams and roentgenographic skeletal surveys, obtained on 170 patients with breast carcinoma, was made to evaluate the diagnostic efficacy of these techniques in detecting metastatic bone lesions. The bone scans were abnormal in 81 patients, while the roentgenograms were abnormal in only 51. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225325

    authors: Joo KG,Parthasarathy KL,Bakshi SP,Rosner D

    更新日期:1979-01-01 00:00:00

  • Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma.

    abstract::The priming action of estradiol and the antiestrogen tamoxifen (TMX) on progesterone receptor (PgR) synthesis has been investigated in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor model testing different priming times. Rats received either TMX or estradiol benzoate (E2B) for 3 or 7 days. Tumors were as...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226488

    authors: Boccardo F,Cerruti G,De Menech R,Valenti G,Zanardi S

    更新日期:1987-01-01 00:00:00

  • Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

    abstract:OBJECTIVE:Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables. METHODS AND RESULTS:Univariate, multivariate, and elastic net modeling...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000442710

    authors: Jatoi A,Vierkant RA,Hawthorne KM,Block MS,Ramus SJ,Larson NB,Fridley BL,Goode EL

    更新日期:2016-01-01 00:00:00

  • Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.

    abstract::Tumor cell apoptosis, proliferation and p27 expression using an in situ apoptosis detection kit, anti-Ki67 antibody and anti-p27 antibody were investigated in 171 colorectal adenocarcinoma specimens, together with the assessment of mutated p53 expression. No apparent association was observed among p27 expression, muta...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012078

    authors: Tenjo T,Toyoda M,Okuda J,Watanabe I,Yamamoto T,Tanaka K,Ohtani M,Nohara T,Kawasaki H,Tanigawa N

    更新日期:2000-01-01 00:00:00

  • Intensive chemotherapy plus recombinant human granulocyte-colony stimulating factor support for distant metastatic nasopharyngeal carcinoma. A preliminary report.

    abstract::Nasopharyngeal carcinoma (NPC) has been shown to be highly responsive to chemotherapy. The major limiting toxicity was myelotoxicity. Recently, the role of granulocyte colony-stimulating factor (G-CSF) in reducing chemotherapy-induced neutropenic sepsis has been well established. In this study, we tested whether recom...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227658

    authors: Wang CH,Wang HM,Chen JS,Chang WJ,Lai GM

    更新日期:1997-01-01 00:00:00

  • Immunohistological approach to tumor diagnosis.

    abstract::Immunoperoxidase methods permit the demonstration of a variety of antigens in routinely processed tissues. The morphological detail obtained by this procedure is comparable to orthodox haematoxylin and eosin stained sections, and so offers the diagnostic pathologist the opportunity of simultaneously identifying normal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:

    authors: Taylor CR

    更新日期:1978-01-01 00:00:00

  • Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.

    abstract:BACKGROUND:Bevacizumab (Avastin) significantly improves overall survival (OS) and progression-free survival (PFS) when combined with first-line irinotecan (IFL) plus bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer (CRC). This open-label, phase IV trial evaluated the efficac...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000229787

    authors: Sobrero A,Ackland S,Clarke S,Perez-Carrión R,Chiara S,Gapski J,Mainwaring P,Langer B,Young S,AVIRI Trial investigators.

    更新日期:2009-01-01 00:00:00